Navigation Links
Kendle Appoints Ken Hintze, PhD, Vice President, Global Clinical Safety & Pharmacovigilance
Date:10/1/2007

vices worldwide. We deliver innovative and robust clinical development solutions - from first-in-human studies through market launch and surveillance - to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions - North America, Europe, Asia/Pacific, Latin America and Africa - to meet customer needs. With the expertise of our more than 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.

Forward-Looking Statements

This release contains information about management's view of Kendle's future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, but not limited to, those set forth in the "Risk Factors" section of the Company's latest Form 10-K and other filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press release represent the company's views as of the date of this press release and these views could change. However, while the company may elect to update these forward-looking statements at some point, the company specifically disclaims any obligation to do so other than as required by federal securities laws. These forward-looking statements should not be relied upon
'/>"/>

SOURCE Kendle International Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Pasierb, President ,, NEW YORK, Dec. 14 ... the Future study (MTF) -- the largest survey on ... 12th graders -- underscores that teens, intentional abuse of ... a cause for concern, with an alarming number of ... relatives. ,, Teen Abuse of Medication ...
(Date:12/14/2009)... 2009, the United States Court of Appeals, Tenth Circuit, ... are "plans" and therefore subject to federal jurisdiction. (US ... that contracts issued by insurance companies may be subject ... US vs. Frost is the first case an ... "plan," because, as the government claimed in this case, ...
(Date:12/14/2009)... bump in odds is small and shouldn,t worry most ... -- Older women who take antidepressants may have a ... death compared to women not on the medications, a ... different from clinical significance," stressed Dr. Jordan W. Smoller, ... and lead author of a report in the Dec. ...
(Date:12/14/2009)... treated and highly stigmatized, according to psychiatrists Charles ... Ph.D. So these Washington University physicians have written ... "Demystifying Psychiatry," Zorumski and Rubin, who have more ... and helping patient families, say some of the ... from a lack of understanding psychiatry and what ...
(Date:12/14/2009)... Quickly and Accurately for Biopsy , ... ... Dilon Diagnostics announced today that the U.S. Food and Drug ... for molecular imaging biopsy guidance. , , ,GammaLMc® is ... Gamma Camera. The GammaLMc® (GL) system will help doctors accurately ...
Breaking Medicine News(10 mins):Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 2Health News:Partnership for a Drug-Free America(R) Responds to 2009 Monitoring the Future Study Results 3Health News:Insurance Now Subject to Federal Jurisdiction 2Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2
... the President,s Cancer Panel, investigators at the U.S. EPA,s Office of ... EPA Administrator to use regulatory authorities authorized by Congress to protect ... ... Atlanta, GA (PRWEB) January 22, 2009 -- A growing ...
... Although primary prostate surgery or radiotherapy is successful in many ... of the disease, which is most often first detected by ... affects 30% to 40% of patients after surgery. One risk ... prostate after surgery, will affect about a third of men. ...
... BROOK, Ill., Jan. 22 University HealthSystem,Consortium (UHC) ... it has,awarded agreements for patient satisfaction measurement services ... supplier has been awarded,a 3-year agreement with options ... 1, 2009. , Under ...
... International Retail Expansion, With Near Term Focus on Top ... ExtensionIRVINE, Calif., Jan. 21 University Medical ... and efficacy-based skin and beauty care products sold at ... U.S., announced today that it has appointed Tom Roche ...
... 21 The following statement can be attributed ... BlueCross:"Capital BlueCross has consistently said two things: We ... other merger. But we have urged public policy ... this proposed merger without conditions, because without conditions ...
... Omnicell, Inc. (Nasdaq: OMCL ), a leading provider of ... to discuss the Company,s fourth quarter 2008 financial results. , ... webcast, ... Randall Lipps, chairman, president and chief executive officer, ...
Other Medicine News:Health News:Scientists and Investigators Cite Need for Radon Regulation to Prevent Lung Cancer- Call Current EPA Efforts Ineffective 2Health News:Scientists and Investigators Cite Need for Radon Regulation to Prevent Lung Cancer- Call Current EPA Efforts Ineffective 3Health News:Scientists and Investigators Cite Need for Radon Regulation to Prevent Lung Cancer- Call Current EPA Efforts Ineffective 4Health News:Treatments after prostate surgery reported in the Journal of Urology 2Health News:Treatments after prostate surgery reported in the Journal of Urology 3Health News:University HealthSystem Consortium Announces Dual Award for Patient Satisfaction Measurement Services 2Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 2Health News:University Medical Pharmaceuticals Appoints Tom Roche as Senior Vice President, Global Sales and Marketing 3Health News:Capital Blue Cross Issues Statement on Withdrawal of Merger 2Health News:Omnicell to Release Fourth Quarter 2008 Earnings Results on January 29 2
(Date:12/14/2009)... Dec. 14 Perry Baromedical, international leader ... the launch of the Sigma Elite, with extended ... the Sigma Elite is available on each monoplace ... has a Patent Pending. ,, The Sigma Elite ... Capture Via Computerized System for Each Dive ...
(Date:12/14/2009)... 14 Greenway Medical Technologies, Inc. ... Prime Suite (®) 2011, is ... EHR, additionally certified for Child Health and ... Prime Suite 2011 achieved the higher ... offered by the Certification Commission for Health ...
(Date:12/14/2009)... ,Dec. 14 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. ... it had received a complete response letter from ... to its New Drug Application ("NDA") for Onrigin(TM) ... letter indicates that the FDA cannot approve the ... recommendations to address remaining issues. ,, Alan Kessman, ...
Breaking Medicine Technology:Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 2Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 3Greenway Medical Technologies' PrimeSuite 2011 Receives CCHIT 2011 Comprehensive Certification 4Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 1Major clinical study rejects cancer safety fears of most common heartburn treatment 56590 2UAB researchers find TB prevention therapy is cost effective option 56588 1UAB researchers find TB prevention therapy is cost effective option 56588 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 1Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 2Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 3Four fifths of businesses foresee problems maintaining operations if H1N1 flu outbreak 56586 4
... Education campaign coincides with Pain Awareness Month, OAKBROOK ... of life, right? Maybe not. Pain is actually one ... untreated pain can have,serious effects -- slowed recovery times, ... The Joint Commission is launching a national campaign to ...
... (Nasdaq: QGLY ), http://www.quigleyco.com, announced ... its wholly owned subsidiary, Quigley,Pharma, http://www.QuigleyPharma.com, ... compound QR448(a) to prevent the transmission of,Infectious Bronchitis ... old,commercial broiler chickens, a consumer meat type bird. ...
Other Medicine Technology:Joint Commission Urges Patients to 'Speak Up' About Pain 2Joint Commission Urges Patients to 'Speak Up' About Pain 3Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens 2Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens 3Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: